Stabilizing aqueous inkjet ink compositions
US-2024400846-A1 · Dec 5, 2024 · US
US12234310B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12234310-B2 |
| Application number | US-202117351924-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 18, 2021 |
| Priority date | Dec 20, 2018 |
| Publication date | Feb 25, 2025 |
| Grant date | Feb 25, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is a blood-compatible polymer represented by Formula 1. A polymer obtained by grafting a fluorinated methacrylate onto a polyvinylidene fluoride copolymer and provided in one aspect of the present invention is a polymer with blood compatibility, and may provide a blood-compatible material with hydrophobicity. In addition, it is possible to provide a material with controlled contact angle and surface energy properties by controlling the hydrogen fluoride length of the fluorinated methacrylate monomer for modification. Furthermore, it is possible to provide coating with controlled surface properties and blood compatibility through a simple process. Furthermore, it is possible to provide a freestanding polymer film with blood compatibility.
Opening claim text (preview).
The invention claimed is: 1. A blood-compatible polymer which is grafted copolymer of vinylidene fluoride (VDF) and chorotrifluoroethylene (CTFE) grafted only with monomer of fluorine-based methacrylate, wherein the fluorine-based methacrylate is represented by the below formula A: wherein k is an integer of 0 to 6, and wherein the blood-compatible polymer is represented by Formula 1 below: in Formula 1 above, x is a mole fraction and is a real number satisfying 0<x<1, y is a mole fraction and is a real number satisfying 0<y<1, z is a mole fraction and is a real number satisfying 0<z<1, wherein x+y+z=1, n is an integer of 5 to 200, and k is an integer of 0 to 6. 2. A method for preparing a blood-compatible polymer of claim 1 , the method comprising mixing a metal catalyst, a ligand, a solvent, and a fluorinated methacrylate monomer by using a copolymer (P(VDF-CTFE)) of vinylidene fluoride (VDF) and chlorotrifluoroethylene (CTFE) as a macro initiator to prepare a mixed solution. 3. The method according to claim 2 , wherein the fluorinated methacrylate monomer is one or more selected from the group consisting of trifluoroethyl methacrylate (TFEMA), pentafluoropropyl methacrylate (PFPMA), heptafluorobutyl methacrylate (HFBMA), and nonafluorohexyl methacrylate. 4. A blood-compatible polymer composition comprising a blood-compatible polymer of claim 1 and a solvent. 5. The blood-compatible polymer composition according to claim 1 , wherein the composition is applied to a device selected from the group consisting of a blood container, in vitro blood circulation equipment, and body transplant medical equipment. 6. A method for preparing a hydrophobic thin film, the method comprising: dissolving the polymer of claim 1 in a solvent to prepare a mixed solution; and coating the mixed solution. 7. The method according to claim 6 , wherein the solvent is one or more selected from the group consisting of trifluorotoluene, acetone, ethylmethylketone, tetrahydrofuran, dimethylformamide, chloroform, and N-methyl-2-pyrrolidone (NMP). 8. The method according to claim 6 , wherein the coating is performed by one or more methods selected from the group consisting of spin coating, dip coating, roll coating, solution coating, and spray coating. 9. A freestanding polymer film comprising the blood-compatible polymer of claim 1 . 10. The freestanding polymer film according to claim 9 , wherein the polymer film is applied to a device selected from the group consisting of a blood container, in vitro blood circulation equipment, and body transplant medical equipment.
halogenated · CPC title
halogenated · CPC title
halogenated · CPC title
Manufacture of films or sheets · CPC title
Macromolecular materials · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.